BusinessRadioMedix Inc. successfully completed the Phase I/ II clinical studies for AminoMedix ™ used for radiation kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT)By Nasdaq OMXOct 20, 2016, 6:30 AM UTC
BusinessRadioMedix successful installations of SmartMedix and All in One (AIO) fully automated radiosynthesizers in USA.By Nasdaq OMXSep 12, 2016, 10:00 AM UTC
